Journal of Surgical Research
Volume 157, Issue 1 , Pages 55-62 , November 2009

Denaturing High Performance Liquid Chromatography Detection of SDHB, SDHD, and VHL Germline Mutations in Pheochromocytoma

  • Goswin Y. Meyer-Rochow, F.R.A.C.S.

      Affiliations

    • Cancer Genetics, Hormones, and Cancer Group, Kolling Institute of Medical Research, Royal North Shore Hospital and University of Sydney, Sydney, Australia
    • University of Sydney Department of Endocrine Surgery, Royal North Shore Hospital, St Leonards, Australia
    • ,
  • Janine M. Smith, M.B.Ch.B.

      Affiliations

    • Department of Clinical Genetics, The Children's Hospital at Westmead and University of Sydney, Westmead, NSW, Australia
    • ,
  • Anne-Louise Richardson, B.Sc.

      Affiliations

    • Cancer Genetics, Hormones, and Cancer Group, Kolling Institute of Medical Research, Royal North Shore Hospital and University of Sydney, Sydney, Australia
    • ,
  • Deborah J. Marsh, Ph.D.

      Affiliations

    • Functional Genomics Laboratory, Hormones and Cancer Group, Kolling Institute of Medical Research, Royal North Shore Hospital, and University of Sydney, Sydney, Australia
    • ,
  • Stan B. Sidhu, Ph.D.

      Affiliations

    • Cancer Genetics, Hormones, and Cancer Group, Kolling Institute of Medical Research, Royal North Shore Hospital and University of Sydney, Sydney, Australia
    • University of Sydney Department of Endocrine Surgery, Royal North Shore Hospital, St Leonards, Australia
    • ,
  • Bruce G. Robinson, M.D.

      Affiliations

    • Cancer Genetics, Hormones, and Cancer Group, Kolling Institute of Medical Research, Royal North Shore Hospital and University of Sydney, Sydney, Australia
    • ,
  • Diana E. Benn, Ph.D.

      Affiliations

    • Cancer Genetics, Hormones, and Cancer Group, Kolling Institute of Medical Research, Royal North Shore Hospital and University of Sydney, Sydney, Australia
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Cancer Genetics Laboratory, Hormones, and Cancer Group, Kolling Institute of Medical Research, Royal North Shore Hospital St. Leonards, Sydney, NSW 2065, Australia.

Received 8 May 2008

References 

  1. Bravo EL, Gifford RW. Current concepts. Pheochromocytoma: Diagnosis, localization and management. N Engl J Med. 1984;311:1298
  2. van der Horst-Schrivers AN, Kerstens MN, Wolffenbuttel BH. Preoperative pharmacological management of phaeochromocytoma. Neth J Med. 2006;64:290
  3. Somasundar P, Krouse R, Hostetter R, et al. Paragangliomas– a decade of clinical experience. J Surg Oncol. 2000;74:286
  4. Lenders JW, Eisenhofer G, Mannelli M, et al. Phaeochromocytoma. Lancet. 2005;366:665
  5. Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346:1459
  6. Amar L, Bertherat J, Baudin E, et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol. 2005;23:8812
  7. Gimenez-Roqueplo AP, Lehnert H, et al. Phaeochromocytoma, new genes and screening strategies. Clin Endocrinol (Oxf). 2006;65:699
  8. Bornstein SR, Gimenez-Roqueplo AP. Genetic testing in pheochromocytoma: Increasing importance for clinical decision making. Ann N Y Acad Sci. 2006;1073:94
  9. Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab. 2006;91:827
  10. Frueh FW, Noyer-Weidner M. The use of denaturing high-performance liquid chromatography (DHPLC) for the analysis of genetic variations: Impact for diagnostics and pharmacogenetics. Clin Chem Lab Med. 2003;41:452
  11. O'Donovan MC, Oefner PJ, Roberts SC, et al. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics. 1998;52:44
  12. Schiavi F, Boedeker CC, Bausch B, et al. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA. 2005;294:2057
  13. Greiner TC.Enhanced detection of TP53 mutations using a GC-clamp in denaturing high performance liquid chromatography. Diagn Mol Pathol. 2007;16:32
  14. Wurzburger RJ, Gupta R, Parnassa AP, et al. Use of GC clamps in DHPLC mutation scanning. Clin Med Res. 2003;1:111
  15. Marsh DJ, Theodosopoulos G, Howell V, et al. Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography. Neoplasia. 2001;3:236
  16. Klein B, Weirich G. Brauch H.DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: Usefulness and limitations. Hum Genet. 2001;108:376
  17. Isobe K, Minowada S, Tatsuno I, et al. Novel germline mutations in the SDHB and SDHD genes in Japanese pheochromocytomas. Horm Res. 2007;68:68
  18. Ruiz-Ferrer M, Fernandez RM, Antinolo G, et al. A complex additive model of inheritance for Hirschsprung disease is supported by both RET mutations and predisposing RET haplotypes. Genet Med. 2006;8:704
  19. Pazaitou-Panayiotou K, Kaprara A, Sarika L, et al. Efficient testing of the RET gene by DHPLC analysis for MEN 2 syndrome in a cohort of patients. Anticancer Res. 2005;25:2091
  20. Torrente I, Arturi F, D'Aloiso L, et al. Evaluation of a DHPLC-based assay for rapid detection of RET germline mutations in Italian patients with medullary thyroid carcinoma. J Endocrinol Invest. 2004;27:111
  21. Li WF, Hu Z, Liu XY, et al. [BRCA1 germ line mutations in Chinese early-onset breast cancer patients]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007;24:499
  22. Meyer P, Voigtlaender T, Bartram CR, et al. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany. Hum Mutat. 2003;22:259
  23. Kang HC, Kim IJ, Park JH, et al. Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families. Hum Mutat. 2002;20:235
  24. Masciari S, Larsson N, Senz J, et al. Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet. 2007;44:726
  25. Spurlock G, Griffiths S, Uff J, Upadhyaya M. Somatic alterations of the NF1 gene in an NF1 individual with multiple benign tumours (internal and external) and malignant tumour types. Fam Cancer. 2007;6:463
  26. Casula M, Colombino M, Satta MP, et al. Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy. Eur J Cancer. 2007;43:137
  27. Liu HX, Li Y, Jiang XD, et al. Mutation screening of mismatch repair gene Mlh3 in familial esophageal cancer. World J Gastroenterol. 2006;12:5281
  28. Yuan Y, Huang YQ, Cai SR, et al. Genetic characterization of Chinese hereditary non-polyposis colorectal cancer by DHPLC and multiplex PCR. Jpn J Clin Oncol. 2004;34:660
  29. Wang XL, Yuan Y, Zhang SZ, et al. Clinical and genetic characteristics of Chinese hereditary nonpolyposis colorectal cancer families. World J Gastroenterol. 2006;12:4074
  30. Zhang Y, Liu X, Fan Y, et al. Germline mutations and polymorphic variants in MMR, E-cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China. Int J Cancer. 2006;119:2592
  31. Zhou JN, Chen SQ, Zhang XM, et al. A novel APC gene germline mutation in a familial adenomatous polyposis pedigree. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006;23:388
  32. Crepin M, Pigny P, Escande F, et al. Evaluation of denaturing high performance liquid chromatography for the mutational analysis of the MEN1 gene. J Mol Endocrinol. 2006;36:369
  33. Park JH, Kim IJ, Kang HC, et al. Germline mutations of the MEN1 gene in Korean families with multiple endocrine neoplasia type 1 (MEN1) or MEN1-related disorders. Clin Genet. 2003;64:48
  34. Howell VM, Cardinal JW, Richardson AL, et al. Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidism. J Mol Diagn. 2006;8:559
  35. Keller G, Hartmann A, Mueller J, et al. Denaturing high pressure liquid chromatography (DHPLC) for the analysis of somatic p53 mutations. Lab Invest. 2001;81:1735
  36. Gross E, Kiechle M, Arnold N. Mutation analysis of p53 in ovarian tumors by DHPLC. J Biochem Biophys Methods. 2001;47:73
  37. Igloi GL. Single-nucleotide polymorphism detection using peptide nucleic acids. Expert Rev Mol Diagn. 2003;3:17
  38. Boutin P, Vasseur F, Samson C, et al. Routine mutation screening of HNF-1alpha and GCK genes in MODY diagnosis: How effective are the techniques of DHPLC and direct sequencing used in combination?. Diabetologia. 2001;44:775
  39. Nickerson ML, Weirich G, Zbar B, et al. Signature-based analysis of MET proto-oncogene mutations using DHPLC. Hum Mutat. 2000;16:68
  40. Liu W, Smith DI, Rechtzigel KJ, et al. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res. 1998;26:1396
  41. Gross E, Arnold N, Goette J, et al. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet. 1999;105:72
  42. Richards FM, Webster AR, McMahon R, et al. Molecular genetic analysis of von Hippel-Lindau disease. J Intern Med. 1998;243:527
  43. Iliopoulos O. von Hippel-Lindau disease: Genetic and clinical observations. Front Horm Res. 2001;28:131
  44. Stolle C, Glenn G, Zbar B, et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat. 1998;12:417
  45. Pack SD, Zbar B, Pak E, et al. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization. Cancer Res. 1999;59:5560

PII: S0022-4804(08)00527-1

doi: 10.1016/j.jss.2008.07.043

Journal of Surgical Research
Volume 157, Issue 1 , Pages 55-62 , November 2009

Article Tools

* Image Usage & Resolution